MANUFACTURERS LIFE INSURANCE COMPANY, THE

Insurance

Position in ELVN — Enliven Therapeutics, Inc.

CIK 928047 TORONTO, A6

Position in ELVN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,819,698

+$2,900,811 QoQ

Shares Held

75,265

+221.1% QoQ

Ownership

0.103%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#84

of 208 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MANUFACTURERS LIFE INSURANCE COMPANY, THE holds $1,655,634,902 across 242 Biotechnology names. ELVN ranks #55 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	554,085	$275,230,642
2	ALNY	Alnylam Pharmaceuticals, Inc.	893,795	$269,059,108
3	BBIO	BridgeBio Pharma, Inc.	1,955,733	$145,662,993
4	JAZZ	Jazz Pharmaceuticals plc	539,037	$129,891,745
5	ROIV	Roivant Sciences Ltd.	2,988,121	$105,749,602
6	REGN	Regeneron Pharmaceuticals, Inc.	147,961	$92,259,601
7	RPRX	Royalty Pharma plc	678,768	$38,058,521
8	PTCT	Ptc Therapeutics, Inc.	441,957	$36,050,432

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,819,698	75,265	+221.1%	Shares	Defined	2026-08-14
2026-03-31	$918,887	23,441	+21.2%	Shares	Defined	2026-05-15
2025-12-31	$297,774	19,336	-56.1%	Shares	Defined	2026-02-13
2025-09-30	$900,761	44,004	-0.3%	Shares	Defined	2025-11-14
2025-06-30	$885,669	44,151	+242.4%	Shares	Defined	2025-08-14
2025-03-31	$253,753	12,894	-23.4%	Shares	Defined	2025-05-15
2024-12-31	$378,810	16,836	-2.6%	Shares	Defined	2025-02-14
2024-09-30	$441,382	17,282	+25.6%	Shares	Defined	2024-11-13
2024-06-30	$321,664	13,764	+36.3%	Shares	Defined	2024-08-14
2023-12-31	$139,714	10,095	—	Shares	Defined	2024-02-13
No filing history on record for this holder in this stock.